Who Buys Ambroxol from India — 486 Importers Behind a $14.8M Market

The importation of Ambroxol from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like DYVENPRO DISTRIBUCION Y VENTA DE (Ecuador) and HEKO PHARMACY LTD (Tanzania) function as intermediaries, procuring large quantities to supply local pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders and a focus on cost-effectiveness to maintain competitive pricing.

• Hospital Groups: Organizations such as UNICA FARMA, LDA. (Angola) and MOVI HEALTH LLC (Poland) represent hospital networks that import Ambroxol to meet patient needs. Their procurement is driven by therapeutic demand, often involving regular, sizable orders to ensure consistent supply for inpatient and outpatient services.

• Retail Chains: Companies like R.B. PHARMA CO LTD (Cambodia) and OPKO CHILE S.A. (Chile) operate extensive pharmacy chains, importing Ambroxol to stock their outlets. Their buying behavior includes frequent orders to maintain inventory levels across multiple locations, emphasizing product availability and brand reputation.

• Government Procurement: Entities such as VIETNAM CHEMICO-PHARMACEUTICAL (Vietnam) and SAAD MEDICAL (Dominican Republic) engage in tender-based purchasing for public healthcare systems. Their procurement processes are characterized by strict regulatory compliance, competitive bidding, and large-volume orders to supply public hospitals and clinics.

• Re-exporters: Companies like MEDEK PHARMA S.A (Dominican Republic) and LLC SERENE PHARMA (Kyrgyzstan) may import Ambroxol with the intent to re-export to neighboring markets. Their purchasing patterns involve strategic bulk buying to leverage economies of scale and meet the demands of multiple markets.

• Contract Manufacturers: While not explicitly listed among the top buyers, contract manufacturers procure Ambroxol as an active pharmaceutical ingredient (API) for formulation into finished products. Their orders are typically large and aligned with production schedules to fulfill contracts with various clients.

Ecuador

1. Drug Regulatory Authority: National Agency for Regulation, Control, and Health Surveillance (ARCSA).

2. Import Registration Process for Ambroxol: Importers must obtain a sanitary registration from ARCSA, which involves submitting a comprehensive dossier including product details, manufacturing processes, and quality control measures. (subastademedicamentos.compraspublicas.gob.ec)

3. Estimated Timeline for Registration: The registration process typically takes approximately 3 business days for import authorization applications. (subastademedicamentos.compraspublicas.gob.ec)

4. Import Tariff/Duty for HS 30049099: The default duty for HS code 3004901000 in Ecuador is 5%.

Tanzania

1. Drug Regulatory Authority: Tanzania Medicines and Medical Devices Authority (TMDA).

2. Import Registration Process for Ambroxol: Importers are required to register pharmaceutical products with TMDA by submitting an application that includes product information, manufacturing details, and evidence of Good Manufacturing Practice (GMP) compliance.

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the need for additional information or clarification.

4. Import Tariff/Duty for HS 30049099: Specific tariff information for HS code 30049099 in Tanzania is not readily available; importers should consult the Tanzania Revenue Authority for current rates.

Angola

1. Drug Regulatory Authority: National Directorate of Medicines and Equipment (DNME).

2. Import Registration Process for Ambroxol: Pharmaceutical products must be registered with DNME, requiring submission of detailed product dossiers, including clinical data and manufacturing standards.

3. Estimated Timeline for Registration: The registration process may take several months, subject to the evaluation of the submitted documentation.

4. Import Tariff/Duty for HS 30049099: Import duties for pharmaceuticals in Angola vary; importers should refer to the Angolan Customs Authority for specific rates.

Cambodia

1. Drug Regulatory Authority: Department of Drugs and Food (DDF) under the Ministry of Health.

2. Import Registration Process for Ambroxol: Importers must obtain product registration from DDF by providing comprehensive documentation, including product composition, manufacturing process, and quality control measures.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the complexity of the product and the completeness of the application.

4. Import Tariff/Duty for HS 30049099: Cambodia applies a standard import duty rate of 7% for pharmaceuticals under HS code 30049099.

Chile

1. Drug Regulatory Authority: Institute of Public Health (ISP).

2. Import Registration Process for Ambroxol: Pharmaceutical products must be registered with ISP, involving the submission of a detailed dossier that includes product specifications, clinical data, and GMP certification.

3. Estimated Timeline for Registration: The registration process typically takes between 6 to 12 months, depending on the product and the completeness of the application.

4. Import Tariff/Duty for HS 30049099: Chile generally applies a 6% import duty on pharmaceuticals under HS code 30049099.

The demand for Ambroxol in importing countries is primarily driven by the prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and acute respiratory infections. According to the World Health Organization (WHO), lower respiratory infections were among the top causes of death globally in 2024, highlighting the ongoing need for effective mucolytic agents like Ambroxol.

Government healthcare programs and the expansion of universal health coverage have also contributed to increased demand. Many countries have included Ambroxol in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which facilitates procurement through tender-based purchasing. This approach ensures consistent supply and affordability, particularly in low- and middle-income countries. The presence of 486 buyers across 92 countries, as per TransData Nexus data, underscores the widespread reliance on Ambroxol to meet public health needs.

The importation of Ambroxol from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like DYVENPRO DISTRIBUCION Y VENTA DE (Ecuador) and HEKO PHARMACY LTD (Tanzania) function as intermediaries, procuring large quantities to supply local pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders and a focus on cost-effectiveness to maintain competitive pricing.

• Hospital Groups: Organizations such as UNICA FARMA, LDA. (Angola) and MOVI HEALTH LLC (Poland) represent hospital networks that import Ambroxol to meet patient needs. Their procurement is driven by therapeutic demand, often involving regular, sizable orders to ensure consistent supply for inpatient and outpatient services.

• Retail Chains: Companies like R.B. PHARMA CO LTD (Cambodia) and OPKO CHILE S.A. (Chile) operate extensive pharmacy chains, importing Ambroxol to stock their outlets. Their buying behavior includes frequent orders to maintain inventory levels across multiple locations, emphasizing product availability and brand reputation.

• Government Procurement: Entities such as VIETNAM CHEMICO-PHARMACEUTICAL (Vietnam) and SAAD MEDICAL (Dominican Republic) engage in tender-based purchasing for public healthcare systems. Their procurement processes are characterized by strict regulatory compliance, competitive bidding, and large-volume orders to supply public hospitals and clinics.

• Re-exporters: Companies like MEDEK PHARMA S.A (Dominican Republic) and LLC SERENE PHARMA (Kyrgyzstan) may import Ambroxol with the intent to re-export to neighboring markets. Their purchasing patterns involve strategic bulk buying to leverage economies of scale and meet the demands of multiple markets.

• Contract Manufacturers: While not explicitly listed among the top buyers, contract manufacturers procure Ambroxol as an active pharmaceutical ingredient (API) for formulation into finished products. Their orders are typically large and aligned with production schedules to fulfill contracts with various clients.

Ecuador

1. Drug Regulatory Authority: National Agency for Regulation, Control, and Health Surveillance (ARCSA).

2. Import Registration Process for Ambroxol: Importers must obtain a sanitary registration from ARCSA, which involves submitting a comprehensive dossier including product details, manufacturing processes, and quality control measures. (subastademedicamentos.compraspublicas.gob.ec)

3. Estimated Timeline for Registration: The registration process typically takes approximately 3 business days for import authorization applications. (subastademedicamentos.compraspublicas.gob.ec)

4. Import Tariff/Duty for HS 30049099: The default duty for HS code 3004901000 in Ecuador is 5%.

Tanzania

1. Drug Regulatory Authority: Tanzania Medicines and Medical Devices Authority (TMDA).

2. Import Registration Process for Ambroxol: Importers are required to register pharmaceutical products with TMDA by submitting an application that includes product information, manufacturing details, and evidence of Good Manufacturing Practice (GMP) compliance.

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the need for additional information or clarification.

4. Import Tariff/Duty for HS 30049099: Specific tariff information for HS code 30049099 in Tanzania is not readily available; importers should consult the Tanzania Revenue Authority for current rates.

Angola

1. Drug Regulatory Authority: National Directorate of Medicines and Equipment (DNME).

2. Import Registration Process for Ambroxol: Pharmaceutical products must be registered with DNME, requiring submission of detailed product dossiers, including clinical data and manufacturing standards.

3. Estimated Timeline for Registration: The registration process may take several months, subject to the evaluation of the submitted documentation.

4. Import Tariff/Duty for HS 30049099: Import duties for pharmaceuticals in Angola vary; importers should refer to the Angolan Customs Authority for specific rates.

Cambodia

1. Drug Regulatory Authority: Department of Drugs and Food (DDF) under the Ministry of Health.

2. Import Registration Process for Ambroxol: Importers must obtain product registration from DDF by providing comprehensive documentation, including product composition, manufacturing process, and quality control measures.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the complexity of the product and the completeness of the application.

4. Import Tariff/Duty for HS 30049099: Cambodia applies a standard import duty rate of 7% for pharmaceuticals under HS code 30049099.

Chile

1. Drug Regulatory Authority: Institute of Public Health (ISP).

2. Import Registration Process for Ambroxol: Pharmaceutical products must be registered with ISP, involving the submission of a detailed dossier that includes product specifications, clinical data, and GMP certification.

3. Estimated Timeline for Registration: The registration process typically takes between 6 to 12 months, depending on the product and the completeness of the application.

4. Import Tariff/Duty for HS 30049099: Chile generally applies a 6% import duty on pharmaceuticals under HS code 30049099.

The demand for Ambroxol in importing countries is primarily driven by the prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and acute respiratory infections. According to the World Health Organization (WHO), lower respiratory infections were among the top causes of death globally in 2024, highlighting the ongoing need for effective mucolytic agents like Ambroxol.

Government healthcare programs and the expansion of universal health coverage have also contributed to increased demand. Many countries have included Ambroxol in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which facilitates procurement through tender-based purchasing. This approach ensures consistent supply and affordability, particularly in low- and middle-income countries. The presence of 486 buyers across 92 countries, as per TransData Nexus data, underscores the widespread reliance on Ambroxol to meet public health needs.